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SUMMARY
Antibiotics account for a large part of all hospital pharmacy budgets, but the
actual cost of their prescription is unknown. These costs include intravenous
administration, labour, serum antibiotic assay, monitoringofhaematological and
biochemical indices, disposal ofsharps andadverse effects. An in-house method
of costing antibiotic therapy is presented, to quantify these hidden expenses.
Since not only an awareness, but an accurate quantification, of hidden costs
is required, a study of various hospital procedures relating directly to antibiotic
therapy was undertaken inan acute medical ward; this involved the identification
ofparticular staff members performing various procedures, consumables used
and time taken. The cost offive-day courses ofgentamicin, penicillin G,
ampicillin, flucloxacillin, cefuroxime, ceftotaxime and erythromycin has been
calculated; drug and hidden costs foreach arepresentedgraphically forcompar-
ison. The breakdown cost for gentamicin is presented to illustrate the method.
The costing ofadverse effects has not been attempted. We suggest that costings
ofthis sort are used in cost-benefit analysis ofantibiotic use. These calculations
have been incorporated into a computerspreadsheet and this costing service will
be offered to clinical areas of our hospital.
INTRODUCTION
Financial restraints on the National Health Service have increased in recent years.
One area in which there is scope for rationalisation and cost savings is drug
prescribing. Antibiotics account for a large part of all hospital pharmacy budgets,
but the actual cost of their prescription is unknown. It is a widely held belief
among health care staff in general that the cost of antibiotic therapy is equal
to the cost of the drug itself. Seldom considered are the 'hidden costs' such as
maintenance of intravenous access, labour, serum antibiotic assay, monitoring
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of haematological and biochemical indices and waste disposal.1 2'3 Almost never
considered are those extra costs due to adverse effects of antibiotics in terms of
finance,4 human suffering5 and environmental deterioration.6
In order to obtain a more accurate assessment ofthe cost of antibiotic therapy we
have developed a costing structure within which subtotals will vary depending on
the antibiotic and the hospital area in question. To assess the cost of antibiotics
used in an acute medical ward, a study of procedures relating directly to antibiotic
therapy was undertaken.
METHODS
After group discussion it was concluded that for any antibiotic the total cost could
be divided into eight cost categories (Table 1). The quantification of these cost
categories requires, first, the basic costs of consumables, labour, transport and
incineration of waste, and secondly, knowledge of consumables used and time
spent by the various grades ofstaffon each ofthe procedures involved. The basic
costs within these eight categories were obtained as follows: antibiotic costs were
obtained from the Monthly Index ofMedical Specialities (MIMS), contract costs of
other consumables were obtained from the hospital purchasing department and
the pharmacy, costs of standard haematological and biochemical tests (tests
performed to assess the adverse effects of the antibiotic used, for example serum
urea and electrolyte measurement for nephrotoxic antibiotics such as gentamicin
and vancomycin) were obtained from their respective departments, costs of
TABLE I
Eight cost categories making up the cost ofany antibiotic course
Cost category Summarised costs
1.
2.
Antibiotic
Maintenance of IV access
3. Drug delivery
4. Drug monitoring
5. Dose readjustment
6. General monitoring
7. Sharps disposal
8. Adverse effects
The drug itself
Insertion of an IV cannula and maintenance ofits
patency
Administration of the drug to the patient
Measurement of serum antibiotic to ensure
therapeutic and to avoid toxic levels
Modification of the dose of antibiotic following
serum antibiotic measurement
Haematological and biochemical indices relating
to the use of the drug. For example, urea and
electrolytes are measured during a course of a
nephrotoxic antibiotic
Sharps are packed in plastic sharps boxes; these
boxes are then packed in clinical waste bags,
delivered to the place of incineration and
incinerated
A substantial cost: the costing of these has not
been attempted in this study
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labour were obtained from the various personnel departments, and information
on employers' National Insuranceand Superannuation contributionswasobtained
from the Departmentof Health and Social Services. For thelabour categories staff
nurse and porter, the most commonly occurring levels of each of these staff
grades was taken as representative - gradeD staff nurse and grade3 porter. This
simplification was not necessary in the case of the junior house officer labour
category as all the participating members of staff in this category were employed
at the basic point on the scale.
The times taken and consumables involved in the performanceof various hospital
procedures relating directly to antibiotic therapy were studied over a three month
period in the acute medical ward. Intravenous cannula insertion, drug delivery
and drawing of blood for laboratory tests were performed by the junior house
officer. Packing of full sharps boxes into clinical waste bags and erecting new,
empty ones was performed by the staff nurse. Portering staff are involved in the
delivery of laboratory samples from the ward to the laboratory and in collection
and transport of clinical waste bags. For delivery of laboratory samples from the
ward to the laboratory, laboratory staff recorded the time taken to walk the same
route. For collection of clinical waste bags, simulation was not possible and so the
cost of this time has not been included. In the study the staff memberperforming
a particular procedure recorded their own name, grade, the procedure, and
the time taken and any consumables involved from setting out to perform the
procedure to total completion of it, including disposal of waste and handwashing,
if appropriate.
Also recorded was the number of gentamicin courses occurring in the ward, the
length of each and how many times serum gentamicin and serum urea and
electrolyte measurements were performed during each course for monitoring
purposes. For each serum gentamicin assay performed it was noted whether or
not the dose was readjusted, and how much time this process took. The number
of courses of the other antibiotics were not noted as serum assay of these is not
normally required. To assess the proportion of a sharps disposal box occupied by
waste from the various antibiotic course regimens, the precise amount of waste
for each regimen was calculated. In each case the waste was placed in the box
and the proportion filled was noted; this varied from 33% for gentamicin to 50%
for ampicillin.
It has been assumed that all blood specimens sent to the laboratory in a specimen
bag for any routine test require the same time for the junior house officer and
the porter. The cost of ward consumables for serum gentamicin and serum urea
and electrolyte measurements were noted specifically. It has also been assumed
that all antibiotics require the same time for administration by the junior house
officer. The consumables for particular antibiotic courses were noted specifically
where possible, and the times taken for the various procedures were arrived at by
calculating average values (Table II). The consumables used in the various pro-
cedures were determined by noting the minimum number necessary to perform a
particular procedure: it was found that serum gentamicin and serum urea and
electrolyte measurements were each performed once for each course of genta-
micin, and calculations were made on this basis. No dose readjustments were
needed after any serum gentamicin assay, so this cost category was considered to
be zero forthisstudy. The cost ofsharps disposal was based onthe most common
© The Ulster Medical Society, 1993.
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TABLE II
Hospital procedures relating to antibiotic therapy: times taken, consumables
used and staffmembers involved
Procedure
(Cost Measure- Time Time
category Staff ments (range) (mean) Consumables
number) member (number) min min
Insertion of
IV cannula
(2)
Drug
delivery
(3)
Drawing of
blood
(4+6)
Sharps box
(7)
Deliveryof
blood
specimens
to labor-
atory (4+6)
Junior
house
officer
Junior
house
officer
Junior
house
officer
Staff
nurse
Porter A
(simulated
by labor-
oratory
staff)
69
184
4-9 6-7 IV cannula x 1
anticoagulant x 1
10ml syringe x 1
cotton wool x 1
alcohol swab x 1
bandage x l
4-7 For 80mg gentamicin:
needle x 1
2ml syringe x 1
For lg erythromycin:
20ml sterile water x 1
20ml syringe x 1
needle x 1
For 1-5g cefuroxime,
2g cefotaxime,
1g flucloxacillin,
1g ampicillin and
1 g 29 penicillin G:
10ml sterile water x 1
10ml syringe x 1
needle x 1
5-3 For serum gentamicin
assay; peak and trough:
10ml syringe x 2
needle x 2
alcohol swab x 2
cotton wool x 2
blood bottle x 2
specimen bag x 1
2-6 4-0
90
41
41 5-9 6*9
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sharps box in use, how much waste filled this particular box to the recommended
level, how many courses of a particular antibiotic regimen this represented,
nursing time, and the cost of transport and incineration.
The resulting data were used to calculate the cost of the following five-day
courses of IV antibiotics: gentamicin 80mg three times daily, penicillin G 1-2g
four times daily, ampicillin 1g four times daily, flucloxacillin 1g four times daily,
cefuroxime 1 *5g three times daily, cefotaxime 2g three times daily, and erythro -
mycin 1g four times daily. The five-day regimen chosen was used to facilitate
comparison of cost between different antibiotics. The itemisation and costing of
the gentamicin regimen is shown in detail. All costs were calculated as contract
costs except the antibiotic cost which is taken from MIMS; the hospital contract
cost of antibiotics and other specific items is not given and these costs therefore
appear as subtotals. Value added tax has not been included on any item as it is
paid by the hospital.
RESULTS
The study of procedures relating directly to antibiotic therapy in an acute medical
ward showed the mean time for insertion of an intravenous cannula to be 6-7
minutes, for drug delivery, 4-7 minutes, for drawing of blood, 5-3 minutes, for
sharps box management, 4 minutes, and for delivery of a blood sample to labor-
atory, 6-9 minutes (Table II).
There were 4 only courses of gentamicin prescribed in the ward during the three
month study period; ranqing in lenqth from five to ninedays, and in each caseone
set of peak and trough serum
gentamicin assays and one
serum urea and electrolyte
measurement was performed.
The dose of gentamicin was
not adjusted in any case.
Table Ill shows the itemised
cost categories and resultant
subtotals for a five-day course
of intravenous gentamicin.
Fig 1 shows these subtotals
graphically; drug costs and
hidden costs account for 35%
and 65% respectively of the
total cost.
General monitoring
Waste disposal
Drug monitoring
Antiobiotic
Drug delivery IV access
Fig 1. Graphical representation of the cost of gentamicin
therapy shown in Table Ill.
The drug costs and hidden costs for 7 different antibiotic regimens, including
gentamicin, calculated according to these methods are shown in Fig 2.
DISCUSSION
For gentamicin, the drug costs and hidden costs account for 35% and 65%
respectively of the total cost. The true ratio of hidden cost to antibiotic cost is
actually greater in this hospital as pharmacy contracting arrangements signific-
antly reduce the drug cost below that shown in the Monthly Index of Medical
Specialities. If the cost of adverse effects were quantified the drug cost contrib-
ution would decrease still further.
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TABLE III
The itemised cost categories and corresponding costs for a five-day course of
intravenous gentamicin 80mg three times daily
Items involved
1. Antibiotic
2. Maintenance of IV access
3. Drug delivery
4. Drug monitoring
(peak and trough serum
levels, measured x 1)
5.
6.
Dose readjustment
General monitoring
(urea and electrolytes
measurement)
7. Waste disposal
8. Adverse effects
80mg gentamicin x 15
IV cannula
anticoagulant
10ml syringe
cotton wool
bandage
alcohol swab
6-7 minutes 9-5 pm JHO
needle x 15
2ml syringe x 15
47 minutes 9-5 pm JHO
23
- 5 minutes OnCall JHO
10ml syringe x 2
needle x 2
alcohol swab x 2
cotton wool x 2
blood bottle x 2
specimen bag
gentamicin assay x 2
10 6 minutes 9-5 pm JHO
6-9 minutes 9-5 pm porter
10ml syringe
needle
alcohol swab
cotton wool
blood bottle
specimen bag
U and E
5-3 minutes 9-5 pm JHO
6 9 minutes 9-5 pm porter
l/3 cost of 101 plastic sharps box
4/3 minutes 9-5 pm staff nurse
Contract cost of waste, transport
and incineration
Nephrotoxicity
Ototoxicity
Bacterial resistance
Superinfection
IV cannula site infection
Total
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Cost category Cost
£23.70
£2.03
£6.41
£28.77
£0.00
£6.29
£0.78
not costed
£67.98
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Gentamicin 80mg tid
Penicillin G 1.2g qid -*HiddenCost
Ampicillin 1g qid UDrug Cost
FlucloxacIllin Ig qid
.....
Cefuroxime 1.5g tid
Cefotaxime 2g tfd ;_5_
Erythromycin g q .= . ...qld
0 20 40 60 80 100 120 140 160 10
Cost (E) forfive day course
Fig 2. Published drug cost versus hidden cost for seven antibiotics
Labourand consumable costsvaryfrom regimen to regimen, accounting forsome
of the variations in hidden costs. Antibiotics which require serum level monitor-
ing, for example gentamicin, have larger hidden costs than those which do not,
for example cefuroxime, other factors being equal. Antibiotics administered four
times per day, for example penicillin G, will have a higher hidden cost than those
administered three times per day, for example cefuroxime. Erythromycin is the
most expensive of the regimens costed (Fig 2) because each dose costs over
eight pounds, because it is administered four times daily, and because it is quite
insoluble; a dose of I g requires twenty millilitres of sterile water to dissolve it.
In this hospital, on -call drug delivery by nursing staff has been about three times
more expensive than that byjunior doctors, and it has therefore been cheaper for
the hospital to employ doctors rather than staff nurses to administer drugs at
night. The recent changes in legislation relating to the workload ofjunior doctors
will change this.
Although the numbers of measurements for all procedures are reasonably high, a
weakness in the study is that the calculations on serum monitoring of gentamicin
are based on data from onlyfourcourses. Although it is recommended procedure,
it is our impression that only a fraction of courses of aminoglycosides are
monitored with serum antibiotic and serum urea and electrolyte measurement.
It has been assumed that all antibiotics require the same time for drug delivery;
this is obviously not the case. For example, a water-soluble antibiotic will take
a shorter time to prepare and administer than a relatively insoluble one; this is
because a larger volume of water and more time are required to prepare an
insoluble antibiotic for therapeutic administration. This is a very difficult area to
quantify accurately as it is routine practice for junior doctors to batch the prepar-
ation and administration of intravenous antibiotics.
As these calculations are complex and ever-changing with cost variation, this
system is at present being installed into the form of computer spreadsheets. The
4(: The Ulster Medical Society, 1993.
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spreadsheet chosen was Microsoft Excel, version 4.0 (Microsoft, UK), running
under Windows 3.1 (Microsoft, UK), on a Compaq Deskpro 386s personal
computer (Compaq Computer Corporation, USA). The system consists of one
'master' spreadsheet, containing all basic costs, linked to many individual anti-
biotic spreadsheets. The antibiotic spreadsheets each begin with a questionnaire
which exactly specifies the course regimen. This information and the appropriate
costsfrom the masterspreadsheet arethen used to calculate the costforeach cost
category; these are then added to obtain the total. Both the published and the
pharmacy contract costs are calculated and each is displayed both numerically
and graphically. Computerisation simplifies (a) cost updating, as the costs are
updated only in the master spreadsheet, (b) calculation, as the calculation
mechanism is permanent in the individual antibiotic spreadsheet, and (c) data
extraction, as only the last section of any antibiotic spreadsheet need be printed.
The system is very flexible as an antibiotic spreadsheet can accommodate any
drug regimen; the answers to the questionnaire are incorporated directly in the
calculations. This costing service will be offered to clinical areas of our hospital; if
costs are required, a questionnaire on the particular regimen would be completed
by the ward and returned to the department of bacteriology for calculation of the
cost of the regimen. A printout from the spreadsheet on cost analysis will be
returned to the ward.
Efficacy of antibiotics is clearly of prime importance. As antibiotic cost awareness
is still in its early stages, the primary issue of efficacy of antibiotics has not been
addressed in this study. Cost is only one of a number of factors to be taken into
account in antibiotic prescribing.
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